EX-99.1 2 d15074dex991.htm EX-99.1

Exhibit 99.1

Synaptics Reports Fourth Quarter and Fiscal Year 2020 Results

Q4’20 Financial Results and Recent Business Highlights

| • |  | Revenue of $277.6 million

| • |  | GAAP Gross Margin of 43.9%; non-GAAP Gross Margin of 46.9%

| • |  | GAAP diluted EPS of $2.55; non-GAAP diluted EPS of $1.24

| • |  | Record EPS results for full-year FY2020 GAAP and non-GAAP diluted EPS

| • |  | Cash and cash equivalents of $763.4 million

| • |  | Completed the divestiture of the Company’s Mobile LCD TDDI business

| • |  | In July, acquired DisplayLink and the rights to Broadcom’s wireless IoT connectivity business

SAN JOSE, Calif., – August 5, 2020 – Synaptics Incorporated (NASDAQ: SYNA), the leading developer of human interface solutions, today reported financial results for its fourth fiscal quarter and fiscal year ended June 27, 2020.

On April 16, 2020 the company completed the divestiture of its Mobile LCD TDDI business, as a result the company received approximately $139 million in cash proceeds. The Company recognized a pre-tax gain on sale of $105 million. The results for the fourth quarter and full fiscal year 2020 include this former business only through the date of the divestiture.

Net revenue for the fourth quarter of fiscal 2020 was $277.6 million. GAAP net income for the fourth quarter of fiscal 2020 was $90.0 million, or $2.55 per diluted share. Non-GAAP net income for the fourth quarter of fiscal 2020 was $43.8 million, or $1.24 per diluted share.

For fiscal 2020, net revenue was $1.33 billion. GAAP net income for fiscal year 2020 was $118.8 million, or $3.41 per diluted share. Non-GAAP net income for fiscal year 2020 was $207.2 million, or $5.95 per diluted share. Fiscal 2020 was a record high year for Synaptics for both GAAP and non-GAAP earnings per diluted share

“Synaptics delivered a strong finish to our fiscal year with fourth quarter revenues exceeding the mid-point of our guidance, gross margins at the high-end of our guidance, and continued improvement in our operational efficiency,” said Michael Hurlston, Synaptics’ president and CEO. “As we look into fiscal 2021, I am excited by the traction we have in our organic business as well as with the new opportunities that our recently closed acquisitions present.”

Cash at the quarter end of June 27, 2020 was $763.4 million. Cash flow from operations during the fourth quarter of fiscal 2020 was $53.5 million.

Business Outlook

On July 23, 2020, the company completed the acquisitions of certain assets and manufacturing rights associated with Broadcom’s wireless IoT connectivity business and on July 31, 2020, completed the purchase of DisplayLink Corp. These newly acquired businesses are now incorporated into our consolidated Q1 fiscal 2021 guidance as of their respective date of close and are part of our IoT business.

Dean Butler, Chief Financial Officer of Synaptics, added, “Fiscal year 2020 was one of the strongest 12-month periods of financial performance in the company’s history with significant margin expansion and a record setting earnings per share. For our first fiscal quarter, we see robust demand for our products and enter the quarter with a strong backlog despite the uncertainties that remain in the macro economy.”

For the first quarter of fiscal 2021, the company expects:

|  | GAAP |  | Non-GAAP Adjustment |  | Non-GAAP
Revenue – Consolidated with Acquisitions |  | $315M to $335 |  | N/A |  | N/A
Gross Margin – Consolidated with Acquisitions |  | N/A* |  | N/A* |  | 47.5 percent to 49.5 percent
Operating Expense – Consolidated with Acquisitions |  | N/A* |  | N/A* |  | $87M to $90M

* | We are unable to provide a reconciliation of these forward-looking non-GAAP financial measures to their respective comparable GAAP financial measures because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount or timing of certain adjustments (including purchase price accounting and related charges associated with the acquisition of DisplayLink Corporation and the acquisition of assets and manufacturing right associated with the wireless IoT connectivity business of Broadcom) that are used to reconcile to these non-GAAP financial measures. These adjustments are currently uncertain or unknown, depend on various factors that are beyond our control, and could have a material impact on, in each case, the most directly comparable GAAP financial measure.

Earnings Call and Supplementary Materials

The Synaptics fourth quarter and fiscal 2020 teleconference and webcast is scheduled to begin at 2:00 p.m. PT (5:00 p.m. ET), on Wednesday, August 5, 2020, during which the company will provide forward-looking information.

Speakers:

| • |  | Michael Hurlston, President and Chief Executive Officer

| • |  | Dean Butler, Chief Financial Officer

| • |  | Jason Tsai, Head of Investor Relations

To participate on the live call, analysts and investors should dial 888-203-1112 (conference ID: 3376718). Supplementary slides, a copy of the prepared remarks, and a live and archived webcast of the conference call will be accessible from the “Investor Relations” section of the company’s Website at https://investor.synaptics.com/.

About Synaptics Incorporated

Synaptics is the pioneer and leader of the human interface revolution, bringing innovative and intuitive user experiences to intelligent devices. Synaptics’ broad portfolio of touch, display, biometrics, voice, audio, and multimedia products is built on the company’s rich R&D, extensive IP and dependable supply chain capabilities. With solutions designed for mobile, PC, smart home, and automotive industries, Synaptics combines ease of use, functionality and aesthetics to enable products that help make our digital lives more productive, secure and enjoyable. (NASDAQ: SYNA) www.synaptics.com.

Join Synaptics on Twitter, LinkedIn, and Facebook or visit www.synaptics.com.

Use of Non-GAAP Financial Information

In evaluating its business, Synaptics considers and uses Non-GAAP Net Income, which we define as net income excluding share-based compensation, acquisition related costs, and certain other non-cash or recurring and non-recurring items the company does not believe are indicative of its core operating performance as a supplemental measure of operating performance. Non-GAAP Net Income is not a measurement of the company’s financial performance under GAAP and should not be considered as an alternative to GAAP net income. The company presents Non-GAAP Net Income because it considers it an important supplemental measure of its performance since it facilitates operating performance comparisons from period to period by eliminating potential differences in net income caused by the existence and timing of share-based compensation charges, acquisition related costs, and certain other non-cash or recurring and non-recurring items. Non-GAAP Net Income has limitations as an analytical tool and should not be considered in isolation or as a substitute for the company’s GAAP net income.

The principal limitations of this measure are that it does not reflect the company’s actual expenses and may thus have the effect of inflating its net income and net income per share as compared to its operating results reported under GAAP. In addition, the company presents components of Non-GAAP Net Income, such as Non-GAAP Gross Margin and Non-GAAP operating expenses, for similar reasons.

We are unable to provide a reconciliation of forward-looking Non-GAAP Gross Margin and Non-GAAP operating expenses to their respective comparable GAAP financial measures because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount or timing of certain adjustments for the acquisition of DisplayLink Corporation and the acquisition of assets and manufacturing right associated with the wireless IoT connectivity business of Broadcom. These adjustments are currently uncertain or unknown, depend on various factors that are beyond our control, and could have a material impact on, in each case, the most directly comparable GAAP financial measure.

As presented in the “Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures” tables that follow, Non-GAAP Net Income and each of the other Non-GAAP financial measures excludes one or more of the following items:

Acquisition/divestiture related costs.

Acquisition/divestiture related costs primarily consist of:

| • |  | amortization of purchased intangibles, which includes acquired intangibles such as developed technology, customer relationships, trademarks, backlog, licensed technology, patents, and in-process technology when post-acquisition development is determined to be substantively complete,

| • |  | inventory adjustments affecting the carrying value of inventory acquired in an acquisition,

| • |  | transitory post-acquisition incentive programs negotiated in connection with an acquired business or designed to encourage post-acquisition retention of key employees, and

| • |  | legal and consulting costs associated with acquisitions or divestitures, including non-recurring post-acquisition costs and services.

These acquisition/divestiture related costs are not factored into the company’s evaluation of its ongoing business operating performance or potential acquisitions, as they are not considered as part of the company’s principal operations. Further, the amount of these costs can vary significantly from period to period based on the terms of an earn-out arrangement, revisions to assumptions that went into developing the estimate of the contingent consideration associated with an earn-out arrangement, the size and timing of an acquisition/divestiture, the lives assigned to the acquired intangible assets, and the maturity of the business acquired. Excluding acquisition/divestiture related costs from Non-GAAP measures provides investors with a basis to compare Synaptics against the performance of other companies without the variability and potential earnings volatility associated with purchase accounting and acquisition/divestiture related items.

Share-based compensation.

Share-based compensation expense relates to employee equity award programs and the vesting of the underlying awards, which includes stock options, deferred stock units, market stock units, performance stock units, phantom stock units and the employee stock purchase plan. Share-based compensation settled with stock, which includes stock options, deferred stock units, market stock units, performance stock units and the employee stock purchase plan, is a non-cash expense, while share-based compensation settled with cash, which includes phantom stock units, is a cash expense. Settlement of all employee equity award programs whether settled with cash or stock varies in amount from period to period and is dependent on market forces that are often beyond the company’s control. As a result, the company excludes share-based compensation from its internal operating forecasts and models. The company believes that Non-GAAP measures reflecting adjustments for share-based compensation provide investors with a basis to compare the company’s principal operating performance against the performance of peer companies without the variability created by share-based compensation resulting from the variety of equity-linked compensatory awards used by other companies and the varying methodologies and assumptions used.

Restructuring costs.

Restructuring costs consist primarily of employee severance and office closure costs, including the reversal of such costs. These costs are cash-based and designed to address cost structure inefficiencies. As a result, the company excludes restructuring costs from its internal operating forecasts and models when evaluating its ongoing business performance. The company believes that Non-GAAP measures reflecting adjustments for restructuring costs provide investors with a basis to compare the company’s principal operating performance against the performance of other companies without the variability created by restructuring costs designed to address cost structure inefficiencies in its business.

Retention program costs.

Retention program costs consist of employee retention arrangement costs designed to ensure operational continuity and support through employee retention. These costs are cash-based and designed to ensure retention of certain key engineering and management employees as we transition the company through senior level management and product focus changes. As a result, the company excludes retention program costs from its internal operating forecasts and models when evaluating its ongoing business performance. The company believes that Non-GAAP measures reflecting adjustments for retention program costs provide investors with a basis to compare the company’s principal operating performance against the performance of other companies without the variability created by retention program costs designed to ensure operational continuity and support through employee retention during a transition of senior level management and product focus changes.

In-process research and development.

In-process research and development represents research and development that is not yet complete. In the context of a business combination, in-process research and development costs will be capitalized and subsequently amortized over an estimated life or impaired. In the context of an asset acquisition, in-process research and development costs will be expensed immediately unless there is an alternative future use. From time to time, we may acquire in-process research and development assets as part of an asset acquisition. If determined to have no alternative future use, these in-process research and development assets will be expensed in the period acquired. As a result, the company excludes in-process research and development costs from its internal operating forecasts and models when evaluating its ongoing business performance. The company believes that Non-GAAP measures reflecting adjustments for in-process research and development costs provide investors with a basis to compare the company’s principal operating performance against the performance of other companies without the variability created by in-process research and development costs.

Gain on sale of assets.

Gain on sale of assets, represents the gain on the sale of our TDDI product line. From time to time, we may sell product line assets from our product portfolio that we believe are not aligned to our product roadmap, are not considered necessary for our future success, or are not performing to our internal requirements. Excluding the gain on sale of assets from our Non-GAAP measures provides investors with a basis to compare the company’s principal operating performance against the performance of other companies without the variability created by infrequent transactions such as the gain on the sale of assets that are not considered to be part of our core business.

Other non-cash items.

Other non-cash items includes non-cash amortization of debt discount and issuance costs. These items are excluded from Non-GAAP results as they are non-cash. Excluding other non-cash items from Non-GAAP measures provides investors with a basis to compare Synaptics against the performance of other companies without the variability associated with other non-cash items.

Recovery on sale of investment.

Recovery on sale of investment, represents the gain on the recovery of an investment in which the cost basis was previously written down to fair value. This item is excluded from Non-GAAP results as the previous write-down was excluded from Non-GAAP results. Excluding recovery on sale of investment from Non-GAAP measures provides investors with a basis to compare Synaptics against the performance of other companies without the variability associated with recovery on sale of investment.

Arbitration settlement, net

Arbitration settlement, net represents the impact of the settlement of an arbitration matter net of related legal and consulting services that is unusual or infrequent. As a result, the company excludes from its internal operating forecasts and models, when evaluating its ongoing business performance, arbitration

settlement amounts net of related costs. The company believes that Non-GAAP measures reflecting an adjustment for arbitration settlements net of related costs provides investors with a basis to compare the company’s principal operating performance against the performance of other companies without the variability created by infrequent, non-recurring or non-routine arbitration settlements net of related costs.

Equity investment loss.

Equity investment loss represents an adjustment in the book value of an equity investment in a minority owned company. The equity investment loss is a non-cash item. As a result, the company excludes equity investment loss from its internal operating forecasts and models when evaluating its ongoing business performance. The company believes that Non-GAAP measures reflecting adjustments for equity investment loss provide investors with a basis to compare the company’s principal operating performance against the performance of other companies without the variability created by non-cash items.

Non-GAAP tax adjustments.

The company forecasts its long-term Non-GAAP tax rate in order to provide investors with improved long-term modeling accuracy and consistency across financial reporting periods by eliminating the effects of certain items in our Non-GAAP net income and Non-GAAP net income per share, including the type and amount of share-based compensation, the taxation of post-acquisition intercompany intellectual property cross-licensing or transfer transactions, and the impact of other acquisition items that may or may not be tax deductible. The company intends to evaluate its long-term Non-GAAP tax rate annually for significant events, including material tax law changes in the major tax jurisdictions in which the company operates, corporate organizational changes related to acquisitions or tax planning opportunities, and substantive changes in our geographic earnings mix.

Forward-Looking Statements

This press release contains forward-looking statements that are subject to the safe harbors created under the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended. Forward-looking statements give our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business, including our expectations regarding the potential impacts on our business of the COVID-19 pandemic, and can be identified by the fact that they do not relate strictly to historical or current facts. Such forward-looking statements may include words such as “expect,” “anticipate,” “intend,” “believe,” “estimate,” “plan,” “target,” “strategy,” “continue,” “may,” “will,” “should,” variations of such words, or other words and terms of similar meaning. All forward-looking statements reflect our best judgment and are based on several factors relating to our operations and business environment, all of which are difficult to predict

and many of which are beyond our control. Such factors include, but are not limited to: the risk that our business, results of operations and financial condition and prospects may be materially and adversely affected by the COVID-19 pandemic and that significant uncertainties remain related to the impact of COVID-19 on our business operations and future results, including our first quarter fiscal 2021 business outlook; the risks as identified in the “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Business” sections of our Annual Report on Form 10-K for the fiscal year ended June 29, 2019 (including that the impact of the COVID-19 pandemic may also exacerbate the risks discussed therein) and our Quarterly Report on Form 10-Q for the fiscal quarter ended March 28, 2020; and other risks as identified from time to time in our Securities and Exchange Commission reports. Forward-looking statements are based on information available to us on the date hereof, and we do not have, and expressly disclaim, any obligation to publicly release any updates or any changes in our expectations, or any change in events, conditions, or circumstances on which any forward-looking statement is based. Our actual results and the timing of certain events could differ materially from the forward-looking statements. These forward-looking statements do not reflect the potential impact of any mergers, acquisitions, or other business combinations that had not been completed as of the date of this release.

For more information contact:

Jason Tsai

Head of Investor Relations

jason.tsai@synaptics.com

SYNAPTICS INCORPORATED

CONSOLIDATED BALANCE SHEETS

(In millions except share data)

(Unaudited)

|  | June 30, 2020 |  |  | June 30, 2019 |
Assets |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 763.4 |  |  | $ | 327.8 |
Accounts receivables, net of allowances of $5.8 at June 30, 2020 and $2.1 at June 30, 2019 |  |  | 195.3 |  |  |  | 230.0 |
Inventories |  |  | 102.0 |  |  |  | 158.7 |
Prepaid expenses and other current assets |  |  | 16.9 |  |  |  | 14.6 |
Total current assets |  |  | 1,077.6 |  |  |  | 731.1 |
Property and equipment at cost, net |  |  | 84.3 |  |  |  | 103.0 |
Goodwill |  |  | 360.8 |  |  |  | 372.8 |
Purchased intangibles, net |  |  | 93.4 |  |  |  | 144.8 |
Non-current other assets |  |  | 77.7 |  |  |  | 58.1 |
Total assets |  | $ | 1,693.8 |  |  | $ | 1,409.8 |
Liabilities and stockholders’ equity |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |
Accounts payable |  | $ | 60.6 |  |  | $ | 98.3 |
Accrued compensation |  |  | 59.5 |  |  |  | 30.4 |
Income taxes payable |  |  | 33.0 |  |  |  | 19.1 |
Other accrued liabilities |  |  | 91.0 |  |  |  | 106.1 |
Total current liabilities |  |  | 244.1 |  |  |  | 253.9 |
Long-term debt |  |  | 586.6 |  |  |  | 468.3 |
Other long-term liabilities |  |  | 44.0 |  |  |  | 30.3 |
Total liabilities |  |  | 874.7 |  |  |  | 752.5 |
Commitments and contingencies |  |  |  |  |  |  |  |
Stockholders’ equity: |  |  |  |  |  |  |  |
Preferred stock; |  |  |  |  |  |  |  |
$.001 par value; 10,000,000 shares authorized; no shares issued and outstanding |  |  | — |  |  |  | — |
Common stock; |  |  |  |  |  |  |  |
$.001 par value; 120,000,000 shares authorized; 65,871,648 and 64,283,948 shares issued, and 34,122,453 and 33,349,735 shares outstanding, respectively |  |  | 0.1 |  |  |  | 0.1 |
Additional paid in capital |  |  | 1,340.2 |  |  |  | 1,266.1 |
Less: 31,749,195 and 30,934,213 treasury shares, respectively, at cost |  |  | (1,222.6 | ) |  |  | (1,192.4 | )
Retained earnings |  |  | 701.4 |  |  |  | 583.5 |
Total stockholders’ equity |  |  | 819.1 |  |  |  | 657.3 |
Total liabilities and stockholders’ equity |  | $ | 1,693.8 |  |  | $ | 1,409.8 |

SYNAPTICS INCORPORATED

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In millions except per share data)

(Unaudited)

|  | Three Months Ended June 30, |  |  | Twelve Months Ended June 30, |
|  | 2020 |  |  | 2019 |  |  | 2020 |  |  | 2019 |
Net revenue |  | $ | 277.6 |  |  | $ | 295.1 |  |  | $ | 1,333.9 |  |  | $ | 1,472.2 |
Acquisition related costs (1) |  |  | 8.1 |  |  |  | 15.4 |  |  |  | 39.7 |  |  |  | 62.7 |
Cost of revenue |  |  | 147.5 |  |  |  | 189.3 |  |  |  | 751.1 |  |  |  | 912.4 |
Gross margin |  |  | 122.0 |  |  |  | 90.4 |  |  |  | 543.1 |  |  |  | 497.1 |
Operating expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Research and development |  |  | 65.0 |  |  |  | 85.6 |  |  |  | 300.1 |  |  |  | 341.6 |
Selling, general, and administrative |  |  | 36.4 |  |  |  | 27.6 |  |  |  | 127.0 |  |  |  | 130.7 |
Acquisition related costs (2) |  |  | 2.9 |  |  |  | 3.2 |  |  |  | 11.7 |  |  |  | 13.4 |
Restructuring costs (3) |  |  | 6.8 |  |  |  | 7.3 |  |  |  | 33.0 |  |  |  | 17.7 |
In-process research and development charge |  |  | (1.3 | ) |  |  | — |  |  |  | 2.4 |  |  |  | — |
Total operating expenses |  |  | 109.8 |  |  |  | 123.7 |  |  |  | 474.2 |  |  |  | 503.4 |
Operating income/(loss) |  |  | 12.2 |  |  |  | (33.3 | ) |  |  | 68.9 |  |  |  | (6.3 | )
Interest and other income, net |  |  | (5.5 | ) |  |  | (4.0 | ) |  |  | (14.6 | ) |  |  | (14.5 | )
Gain on sale of product line |  |  | 105.1 |  |  |  | — |  |  |  | 105.1 |  |  |  | — |
Income/(loss) before income taxes |  |  | 111.8 |  |  |  | (37.3 | ) |  |  | 159.4 |  |  |  | (20.8 | )
Provision for income taxes |  |  | 21.3 |  |  |  | 8.4 |  |  |  | 38.6 |  |  |  | 0.3 |
Equity investment loss |  |  | (0.5 | ) |  |  | (0.5 | ) |  |  | (2.0 | ) |  |  | (1.8 | )
Net income/(loss) |  | $ | 90.0 |  |  | $ | (46.2 | ) |  | $ | 118.8 |  |  | $ | (22.9 | )
Net income/(loss) per share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 2.64 |  |  | $ | (1.35 | ) |  | $ | 3.54 |  |  | $ | (0.66 | )
Diluted |  | $ | 2.55 |  |  | $ | (1.35 | ) |  | $ | 3.41 |  |  | $ | (0.66 | )
Shares used in computing net income per share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  | 34.1 |  |  |  | 34.3 |  |  |  | 33.6 |  |  |  | 34.6 |
Diluted |  |  | 35.3 |  |  |  | 34.3 |  |  |  | 34.8 |  |  |  | 34.6 |

(1) | These acquisition related costs consist primarily of amortization of acquired intangible assets and inventory fair value adjustments associated with acquisitions.

(2) | These acquisition related costs, net consist primarily of amortization associated with certain acquired intangible assets as well as transitory acquisition related compensation plans.

(3) | Restructuring costs primarily include severance costs and facility consolidation costs associated with operational restructurings and acquisitions.

SYNAPTICS INCORPORATED

Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures

(In millions except per share data)

(Unaudited)

|  | Three Months Ended June 30, |  |  | Twelve Months Ended June 30, |
|  | 2020 |  |  | 2019 |  |  | 2020 |  |  | 2019 |
GAAP gross margin |  | $ | 122.0 |  |  | $ | 90.4 |  |  | $ | 543.1 |  |  | $ | 497.1 |
Acquisition related costs |  |  | 8.1 |  |  |  | 15.4 |  |  |  | 39.7 |  |  |  | 62.7 |
Loss/(recovery) on supply commitment |  |  | — |  |  |  | 9.0 |  |  |  | (3.0 | ) |  |  | 9.0 |
Retention costs |  |  | 0.1 |  |  |  | — |  |  |  | 0.5 |  |  |  | — |
Share-based compensation |  |  | — |  |  |  | 0.7 |  |  |  | 2.1 |  |  |  | 3.1 |
Non-GAAP gross margin |  | $ | 130.2 |  |  | $ | 115.5 |  |  | $ | 582.4 |  |  | $ | 571.9 |
GAAP gross margin - percentage of revenue |  |  | 43.9 | % |  |  | 30.6 | % |  |  | 40.7 | % |  |  | 33.8 | %
Acquisition related costs - percentage of revenue |  |  | 2.9 | % |  |  | 5.2 | % |  |  | 2.9 | % |  |  | 4.3 | %
Loss/(recovery) on supply commitment |  |  | — |  |  |  | 3.0 | % |  |  | -0.2 | % |  |  | 0.6 | %
Retention costs |  |  | 0.1 | % |  |  | — |  |  |  | 0.1 | % |  |  | — |
Share-based compensation - percentage of revenue |  |  | — |  |  |  | 0.2 | % |  |  | 0.2 | % |  |  | 0.2 | %
Non-GAAP gross margin - percentage of revenue |  |  | 46.9 | % |  |  | 39.1 | % |  |  | 43.7 | % |  |  | 38.8 | %
GAAP research and development expense |  | $ | 65.0 |  |  | $ | 85.6 |  |  | $ | 300.1 |  |  | $ | 341.6 |
Share-based compensation |  |  | (7.7 | ) |  |  | (8.3 | ) |  |  | (32.3 | ) |  |  | (33.7 | )
Retention costs |  |  | (1.8 | ) |  |  | (1.6 | ) |  |  | (8.4 | ) |  |  | (1.6 | )
Non-GAAP research and development expense |  | $ | 55.5 |  |  | $ | 75.7 |  |  | $ | 259.4 |  |  | $ | 306.3 |
GAAP selling, general, and administrative expense |  | $ | 36.4 |  |  | $ | 27.6 |  |  | $ | 127.0 |  |  | $ | 130.7 |
Share-based compensation |  |  | (8.5 | ) |  |  | (1.3 | ) |  |  | (26.0 | ) |  |  | (22.2 | )
CEO severance |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (2.2 | )
Acquisition/divestiture related costs |  |  | (2.5 | ) |  |  | — |  |  |  | (4.2 | ) |  |  | (1.2 | )
Retention costs |  |  | (1.1 | ) |  |  | (0.9 | ) |  |  | (5.0 | ) |  |  | (0.9 | )
Arbitration settlement, net |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1.7 |
Non-GAAP selling, general, and administrative expense |  | $ | 24.3 |  |  | $ | 25.4 |  |  | $ | 91.8 |  |  | $ | 105.9 |
GAAP operating income/(loss) |  | $ | 12.2 |  |  | $ | (33.3 | ) |  | $ | 68.9 |  |  | $ | (6.3 | )
Share-based compensation |  |  | 16.2 |  |  |  | 10.3 |  |  |  | 60.4 |  |  |  | 59.0 |
Acquisition/divestiture related costs |  |  | 13.5 |  |  |  | 18.6 |  |  |  | 55.6 |  |  |  | 77.3 |
Loss/(recovery) on supply commitment |  |  | — |  |  |  | 9.0 |  |  |  | (3.0 | ) |  |  | 9.0 |
Restructuring costs |  |  | 6.8 |  |  |  | 7.3 |  |  |  | 33.0 |  |  |  | 17.7 |
Retention costs |  |  | 3.0 |  |  |  | 2.5 |  |  |  | 13.9 |  |  |  | 2.5 |
CEO severance |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 2.2 |
In-process research and development charge |  |  | (1.3 | ) |  |  | — |  |  |  | 2.4 |  |  |  | — |
Arbitration settlement, net |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (1.7 | )
Non-GAAP operating income |  | $ | 50.4 |  |  | $ | 14.4 |  |  | $ | 231.2 |  |  | $ | 159.7 |
GAAP net income/(loss) |  | $ | 90.0 |  |  | $ | (46.2 | ) |  | $ | 118.8 |  |  | $ | (22.9 | )
Share-based compensation |  |  | 16.2 |  |  |  | 10.3 |  |  |  | 60.4 |  |  |  | 59.0 |
Acquisition/divestiture related costs |  |  | 13.5 |  |  |  | 18.6 |  |  |  | 55.6 |  |  |  | 77.3 |
Loss/(recovery) on supply commitment |  |  | — |  |  |  | 9.0 |  |  |  | (3.0 | ) |  |  | 9.0 |
Restructuring costs |  |  | 6.8 |  |  |  | 7.3 |  |  |  | 33.0 |  |  |  | 17.7 |
Retention program costs |  |  | 3.0 |  |  |  | 2.5 |  |  |  | 13.9 |  |  |  | 2.5 |
CEO severance |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 2.2 |
In-process research and development charge |  |  | (1.3 | ) |  |  | — |  |  |  | 2.4 |  |  |  | — |
Arbitration settlement, net |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (1.7 | )
Other non-cash items |  |  | 4.8 |  |  |  | 4.6 |  |  |  | 18.8 |  |  |  | 18.0 |
Recovery on sale of investment |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (2.8 | )
Gain on sale of assets |  |  | (105.1 | ) |  |  | — |  |  |  | (105.1 | ) |  |  | — |
Equity investment loss |  |  | 0.5 |  |  |  | 0.5 |  |  |  | 2.0 |  |  |  | 1.8 |
Non-GAAP tax adjustments |  |  | 15.4 |  |  |  | 6.6 |  |  |  | 10.4 |  |  |  | (18.9 | )
Non-GAAP net income |  | $ | 43.8 |  |  | $ | 13.2 |  |  | $ | 207.2 |  |  | $ | 141.2 |
GAAP net income/(loss) per share - diluted |  | $ | 2.55 |  |  | $ | (1.35 | ) |  | $ | 3.41 |  |  | $ | (0.66 | )
Share-based compensation |  |  | 0.46 |  |  |  | 0.30 |  |  |  | 1.73 |  |  |  | 1.71 |
Acquisition/divestiture related costs |  |  | 0.38 |  |  |  | 0.54 |  |  |  | 1.60 |  |  |  | 2.23 |
Loss/(recovery) on supply commitment |  |  | — |  |  |  | 0.26 |  |  |  | (0.09 | ) |  |  | 0.26 |
Restructuring costs |  |  | 0.19 |  |  |  | 0.21 |  |  |  | 0.95 |  |  |  | 0.51 |
Retention program costs |  |  | 0.09 |  |  |  | 0.07 |  |  |  | 0.40 |  |  |  | 0.07 |
CEO severance |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 0.06 |
In-process research and development charge |  |  | (0.04 | ) |  |  | — |  |  |  | 0.07 |  |  |  | — |
Arbitration settlement, net |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (0.05 | )
Other non-cash items |  |  | 0.14 |  |  |  | 0.13 |  |  |  | 0.54 |  |  |  | 0.44 |
Recovery on sale of investment |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Gain on sale of assets |  |  | (2.98 | ) |  |  | — |  |  |  | (3.02 | ) |  |  | — |
Equity investment loss |  |  | 0.01 |  |  |  | 0.02 |  |  |  | 0.06 |  |  |  | 0.05 |
Non-GAAP tax adjustments |  |  | 0.44 |  |  |  | 0.20 |  |  |  | 0.30 |  |  |  | (0.54 | )
Non-GAAP share adjustment |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (0.08 | )
Non-GAAP net income per share - diluted |  | $ | 1.24 |  |  | $ | 0.38 |  |  | $ | 5.95 |  |  | $ | 4.00 |

SYNAPTICS INCORPORATED

CONDENSED CONSOLIDATED CASH FlOWS

(In millions)

(Unaudited)

|  | Twelve Months Ended June 30, |
|  | 2020 |  |  | 2019 |
Net income/(loss) |  | $ | 118.8 |  |  | $ | (22.9 | )
Non-cash operating items |  |  | 51.2 |  |  |  | 169.1 |
Changes in working capital |  |  | 51.8 |  |  |  | 8.0 |
Provided by operations |  |  | 221.8 |  |  |  | 154.2 |
Acquisitions |  |  | (2.5 | ) |  |  | — |
Proceeds from sale of assets |  |  | 138.7 |  |  |  | — |
Fixed asset & intangible asset purchases |  |  | (16.3 | ) |  |  | (23.7 | )
Proceeds from sales and maturities of investments |  |  | — |  |  |  | 2.8 |
Provided by/(used in) investing |  |  | 119.9 |  |  |  | (20.9 | )
Treasury shares purchased |  |  | (30.2 | ) |  |  | (118.5 | )
Equity compensation, net |  |  | 24.1 |  |  |  | 11.9 |
Proceeds from line of credit |  |  | 100.0 |  |  |  | — |
Provided by/(used in) financing |  |  | 93.9 |  |  |  | (106.6 | )
Effect of exchange rate changes on cash and cash equivalents |  |  | — |  |  |  | 0.1 |
Net change in cash and cash equivalents |  |  | 435.6 |  |  |  | 26.8 |
Cash and cash equivalents at beginning of period |  |  | 327.8 |  |  |  | 301.0 |
Cash and cash equivalents at end of period |  | $ | 763.4 |  |  | $ | 327.8 |
Cash paid for taxes |  | $ | 18.9 |  |  | $ | 16.4 |
Cash refund on taxes |  | $ | 1.3 |  |  | $ | 6.3 |